BCLS ACQUISITION CORP's ticker is BLSA and the CUSIP is G0904B105. A total of 52 filers reported holding BCLS ACQUISITION CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,884,000 | -2.1% | 187,991 | -3.3% | 0.00% | 0.0% |
| Q2 2022 | $1,925,000 | +36.0% | 194,437 | +35.7% | 0.00% | 0.0% |
| Q1 2022 | $1,415,000 | -6.2% | 143,330 | -6.9% | 0.00% | 0.0% |
| Q4 2021 | $1,509,000 | -2.5% | 153,943 | -1.0% | 0.00% | 0.0% |
| Q3 2021 | $1,548,000 | -27.5% | 155,458 | -23.3% | 0.00% | 0.0% |
| Q2 2021 | $2,135,000 | +9.4% | 202,710 | +9.8% | 0.00% | 0.0% |
| Q1 2021 | $1,951,000 | -59.2% | 184,584 | -57.0% | 0.00% | -66.7% |
| Q4 2020 | $4,786,000 | – | 429,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 843,122 | $8,347,000 | 4.65% |
| Logan Stone Capital, LLC | 175,698 | $1,739,000 | 1.28% |
| Samsara BioCapital, LLC | 300,000 | $2,970,000 | 0.79% |
| Bain Capital Life Sciences Investors, LLC | 487,500 | $4,826,000 | 0.57% |
| COMMODORE CAPITAL LP | 250,000 | $2,475,000 | 0.52% |
| Altium Capital Management LP | 100,000 | $990,000 | 0.40% |
| Exos Asset Management LLC | 70,367 | $697,000 | 0.36% |
| RA Capital Management | 1,250,000 | $12,375,000 | 0.33% |
| Boxer Capital, LLC | 500,000 | $4,950,000 | 0.31% |
| PFM Health Sciences, LP | 464,103 | $4,595,000 | 0.18% |